MSCI Perspectives intro episode 145
Vaccine Mandates and Walmart’s Insulin
Some companies are mandating their employees receive vaccine for COVID-19 if they want to continue working at the company. The idea sort of seems like a mandatory health and safety procedure, albeit one with a bit more controversy surrounding it than others. Still, the companies that have a fully vaccinated workforce may be in a better place come winter than those without. We discuss how vaccine mandates are similar to the proactive health and safety policies implemented at companies in more dangerous industries. Then we ask whether Walmart has become a social impact company with its new relatively low-cost insulin product offered to uninsured Americans.
Social Sharing
Vaccine Mandates and Walmart’s Insulin - ESG now episode 145
Vaccine Mandates and Walmart’s Insulin (24:45)
八月 06, 2021
MSCI ESG Now: Episode 145
ep145 - featuring
Featuring:
Sam Block, Vice President, ESG Research, MSCI
Namita Nair, Vice President, ESG Research, MSCI
Subscribe to Our Podcast:
Follow our podcast:
Related content - episode 145
ESG Now Podcast
ESG explored. A rotating cast of researchers on environmental, social, and governance issues join hosts Mike Disabato and Bentley Kaplan as they discuss the most pressing news of the week. But in an enjoyable way.
Previous EpisodesThe Doctor Is Making House Calls: Capturing Exposure to Telehealth
Telehealth is rapidly redefining the mix of health-care delivery systems in many countries, having gotten a major boost during the COVID-19 pandemic.
Read the BlogMSCI ESG Healthcare Funds and SDG 3
We find that only 47 funds that invest globally in healthcare and allied industries had greater than 50% alignment with SDG 3, comprising just 0.51% of all healthcare funds and 15% of total healthcare fund assets.
Access Report